Tenderwize
Retour à la recherche

Adquisición vacuna frente al virus respiratorio sincitial (VRS)

Secretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha·Toledo, Spain·EUR 7.9M·Expired · Jul 10, 2026·Open·Supplies
High valueStructured notice only
Titre original de l'avis

Spain – Vaccines – Adquisición vacuna frente al virus respiratorio sincitial (VRS)

70/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesExpired
Pourquoi ce score ?

Opportunité

70 / 100

Complexité

60 / 100

Facteurs de risque

Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect contract terms or condition...

No procurement documents were analyzed; essential details (e.g., technical specs, contract terms) are unknown.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
Secretaría General de la Consejería de Sanidad de la Junta de Comunidades de Castilla-La Mancha
Pays
Espagne
CPV
33651600 - Vaccines
Date limite
Jul 10, 2026
Valeur estimée
EUR 7.9M

Aperçu

Moderate opportunity

Faits clés

  • EUR 7.9M estimated value
  • Supplies contract
  • 1 lot
  • Duration 13 MONTH
  • Supply of VRS vaccine for adult and high-risk populations
  • Duration of 13 months
Afficher le résumé complet

Open tender for the supply of a vaccine against Respiratory Syncytial Virus (VRS) for adult and high-risk populations in Castilla-La Mancha, Spain. Single lot, estimated value €7,920,000, 13-month contract. EU-funded according to structured data, but XML notice indicates no EU funds. Award criteria 60% quality, 40% price. Selection criteria include annual turnover and references. Deadline 10 July 2026.

Risques

Structured data indicates EU-funded, but XML notice states 'no-eu-funds'. This could affect contract terms or condition...

No procurement documents were analyzed; essential details (e.g., technical specs, contract terms) are unknown.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Annual turnover and references required for eligibility

Administrative

  • Open procedure, electronic submission required
  • Language: Spanish

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

Quality: Co-administration with flu and COVID-19 vaccines (8 points) — 8%Quality: Maximum demonstrated immunity duration (12 points) — 12%Quality: Efficacy evidence in vulnerable subgroups (12 points) — 12%Quality: Level of clinical efficacy evidence (12 points) — 12%Price: Economic offer (40 points) — 40%Quality: Validity period (10 points) — 10%Quality: Pharmaceutical presentation (2 points) — 2%Quality: Replacement for cold chain breakage (4 points) — 4%

Acheteur

Lots (1)

LOT-0000

Adquisición vacuna frente al virus respiratorio sincitial (VRS)

Supply of VRS vaccine for adult and high-risk populations.

SuppliesEU fundedElectronic submission

EUR 7.9M

Valeur estimée

Localisation

ES421, Spain

Durée

13 MONTH

Catégorie

Vaccines

Critères d'attribution

Best price-quality ratio

Date limite

Expired Jul 10, 2026

Détails de la procédure

Date de publication
10 Jun 2026
Langues
Spanish

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
400931-2026

Documents (1)

Appels d'offres similaires